Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 7/20 | 0.64 |
| ▸ | TK1 | P04183 | 2/20 | 0.64 |
| ▸ | BLM | P54132 | 2/20 | 0.63 |
| ▸ | USP2 | O75604 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | EDNRA | P25101 | 1/20 | 0.63 |
| ▸ | HTR2A | P28223 | 1/20 | 0.63 |
| ▸ | RECQL | P46063 | 1/20 | 0.63 |
| ▸ | HBB | P68871 | 1/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | VCP | P55072 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.60 |
| ▸ | HPRT1 | P00492 | 7/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL667796 | 0.88 | TK1 (0.69) | PNPTK1BLMUSP2TSHR | |
| SCHEMBL9960816 | 0.87 | PNP (0.68) | PNPTK1BLMUSP2TSHR | |
| SCHEMBL29286376 | 0.87 | TK1 (0.76) | PNPTK1BLMUSP2TSHR | |
| SCHEMBL18521979 | 0.86 | PNP (0.66) | PNPTK1BLMUSP2TSHR | |
| SCHEMBL6272731 | 0.85 | TK1 (0.74) | PNPTK1HPRT1 | |
| SCHEMBL13397350 | 0.84 | TK1 (0.72) | PNPTK1BLMUSP2TSHR | |
| SCHEMBL8522271 | 0.84 | TK1 (0.76) | PNPTK1KMT2AHPRT1 | |
| SCHEMBL1767748 | 0.84 | PNP (0.74) | PNPTK1BLMUSP2TSHR | |
| SCHEMBL2343359 | 0.84 | PNP (0.70) | PNPTK1BLMUSP2TSHR | |
| SCHEMBL16978925 | 0.84 | PNP (0.60) | PNPTK1BLMUSP2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109799313-B | Nitrogen-doped carbon material nano enzyme based on nucleic acid base or derivative thereof, and preparation method and application thereof | 南京大学 | 2021-07-27 | — | — | CN | claimed |
| CN-109799313-A | Nitrogen-doped carbon material nano enzyme based on nucleic acid base or derivatives thereof and its preparation method and application | 南京大学 | 2019-05-24 | — | — | CN | claimed |
| US-9725474-B2 | Modified nucleic acid | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2017-08-08 | — | — | US | claimed |
| EP-1419247-A2 | METHOD FOR THE PRODUCTION OF NUCLEIC ACIDS CONSISTING OF STOCHASTICALLY COMBINED PARTS OF SOURCE NUCLEIC ACIDS | Direvo Biotech AG (DE) | 2004-05-19 | — | — | EP | claimed |
| WO-2003012100-A2 | METHOD FOR THE PRODUCTION OF NUCLEIC ACIDS CONSISTING OF STOCHASTICALLY COMBINED PARTS OF SOURCE NUCLEIC ACIDS | DIREVO BIOTECH AG (DE) | 2003-02-13 | — | — | WO | claimed |
| EP-4658754-A1 | ALGAE BIOMASS | Algenuity BV (NL) | 2025-12-10 | — | — | EP | disclosed |
| EP-4658093-A1 | FOOD COMPOSITION COMPRISING CHLOROPHYLL-DEFICIENT CHLORELLA BIOMASS WITH HIGH PROTEIN CONTENT >50WT% | Unilever IP Holdings B.V. (NL) | 2025-12-10 | — | — | EP | disclosed |
| EP-4658753-A1 | CHLORELLA MICROALGAE | Algenuity BV (NL) | 2025-12-10 | — | — | EP | disclosed |
| EP-4658084-A1 | FOOD COMPOSITION | Unilever IP Holdings B.V. (NL) | 2025-12-10 | — | — | EP | disclosed |
| WO-2025082420-A1 | AQUEOUS EMULSION, METHOD FOR PREPARING THE SAME, COATING COMPOSITION AND ARTICLE | GUANGDONG HUARUN PAINTS CO., LTD. (CN) | 2025-04-24 | — | — | WO | disclosed |
| EP-4522753-A2 | DOUBLE STRANDED DNA COMPOSITIONS AND RELATED METHODS | Flagship Pioneering Innovations VII, LLC (US) | 2025-03-19 | — | — | EP | disclosed |
| US-20250027033-A1 | MODIFIED STRAINS OF CHLORELLA VULGARIS AND METHOD OF PRODUCTION | ALGENUITY HOLDINGS LTD (GB) | 2025-01-23 | — | — | US | disclosed |
| EP-0504279-A4 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES | — | 1993-02-17 | — | — | EP | disclosed |
| WO-1992020816-A1 | DETERMINATION OF PRODRUGS METABOLIZABLE BY THE LIVER AND THERAPEUTIC USE THEREOF | YALE UNIVERSITY (US) | 1992-11-26 | — | — | WO | disclosed |
| EP-0504279-A1 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES. | CHEMGEN CORP (US) | 1992-09-23 | — | — | EP | disclosed |
| EP-0464112-A1 | A PROCESS FOR THE PREPARATION OF 9-SUBSTITUTED GUANINE DERIVATIVES AND INTERMEDIATES FOR USE IN THE PROCESS. | GEA FARMACEUTISK FABRIK AS (DK) | 1992-01-08 | — | — | EP | disclosed |
| WO-1991009130-A1 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES | CHEMGEN CORPORATION (US) | 1991-06-27 | — | — | WO | disclosed |
| WO-1990011283-A1 | A PROCESS FOR THE PREPARATION OF 9-SUBSTITUTED GUANINE DERIVATIVES AND INTERMEDIATES FOR USE IN THE PROCESS | A/S GEA FARMACEUTISK FABRIK (DK) | 1990-10-04 | — | — | WO | disclosed |
| EP-0303437-A2 | Platinum triamine compounds containing nucleotides or nucleosides as antitumor agents | ENGELHARD CORPORATION (US) | 1989-02-15 | — | — | EP | disclosed |
| EP-0152091-A2 | Method for improving the selective inhibition of the activity of human pancreatic and salivary amylase and an inhibitor preparation therefore | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1985-08-21 | — | — | EP | disclosed |